Related Experiment Video
Updated: Dec 18, 2025

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Cancer-killing, decoy-resistant interleukin-18
Kyohei Nakamura1, Tobias Bald1, Mark J Smyth1
1QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
Immunology and Cell Biology
|June 15, 2020
Abstract:
A recent paper by Zhou et al. describes a new engineered decoy-resistant interleukin-18 with potent antitumor activity and translational potential for cancer immunotherapy.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.5K
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.4K